CTKB — Cytek Biosciences Share News
0.000.00%
Last trade - 00:00- $703.21m
- $450.88m
- $201.49m
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million
Cytek Biosciences, Inc. expected to post a loss of 8 cents a share - Earnings Preview
Cytek Biosciences Q1 revenue rises 6%, slightly misses estimates
Brief: Cytek Biosciences Q1 Revenue USD 44.135 Million
Cytek Biosciences Q4 revenue rises 8%
Brief: Cytek Biosciences Q4 Pretax Profit USD -4.031 Million
Cytek Biosciences prelim Q4 revenue beats estimates
Cytek Biosciences Q3 revenue beats estimates, driven by recurring rev growth
Brief: Cytek Biosciences Q3 Revenue USD 52.293 Million Vs. IBES Estimate USD 51.5 Million
Brief: Cytek Biosciences relocates European HQ to Amsterdam’s life sciences district
Cytek Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytek Biosciences Q2 Revenue USD 45.602 Million Vs. IBES Estimate USD 46.3 Million
Cytek Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Cytek Biosciences Q1 Revenue USD 41.457 Million Vs. IBES Estimate USD 42.7 Million
Cytek Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Cytek Biosciences Q4 Revenue USD 57.5 Million Vs. IBES Estimate USD 59.4 Million